Ge Healthcare Technologies (GEHC) Stock
Global provider of diagnostic imaging and patient monitoring tools. Here's the price, business snapshot, and what's worth knowing about Ge Healthcare Technologies in October 2026.
GE HealthCare Technologies Inc. (GEHC) is a global medical technology and services company focused on diagnostic imaging, ultrasound, patient monitoring, life‑sciences tools and bioprocessing, and healthcare IT. With a market capitalisation around $34.7 billion, the business combines capital equipment sales with recurring revenue from service contracts, consumables and software – a mix that can smooth cyclicality in equipment purchases. Key growth drivers include demand for imaging and diagnostics, expansion of bioprocessing for biologics, and adoption of digital and AI tools to improve workflows. Investors should be aware of sensitivity to hospital and clinic capital spending cycles, competitive pressures, reimbursement and regulatory risk, and supply‑chain dynamics. Management execution and capital allocation also matter for returns. This summary is educational only, not personalised advice: values can rise and fall and past performance is not a guide to the future. Check up‑to‑date filings and consult a financial adviser when assessing suitability for your portfolio.
Why It’s Moving
GE Healthcare Shares Poised for Q4 Rebound as Valuations Hit Attractive Levels
- The stock is currently trading at levels considered attractive by analysts after a period of recent price declines.
- Upcoming earnings reports are identified as the primary catalyst that could trigger a significant stock rebound in the fourth quarter.
- GE Healthcare is highlighted alongside Danaher as one of two beaten-down healthcare stocks with high upside potential for the remainder of the year.
GE Healthcare Shares Poised for Q4 Rebound as Valuations Hit Attractive Levels
- The stock is currently trading at levels considered attractive by analysts after a period of recent price declines.
- Upcoming earnings reports are identified as the primary catalyst that could trigger a significant stock rebound in the fourth quarter.
- GE Healthcare is highlighted alongside Danaher as one of two beaten-down healthcare stocks with high upside potential for the remainder of the year.
Sixth Month Growth Performance
When is the next earnings date for GE HEALTHCARE TECHNOLOGIES INC (GEHC)?
GEHC has a confirmed upcoming earnings report scheduled for October 28, 2026, at 08:30 AM ET before the market opens. This release will cover the company's third-quarter fiscal results for the period ending in September 2026. Investors should note that this date aligns with the firm's consistent historical pattern of reporting quarterly performance in late October.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying GE Healthcare's stock with a target price of $87.99, indicating good growth potential.
Financial Health
GE Healthcare is generating strong profits and cash flow, indicating solid financial performance.
Dividend
GE Healthcare's low dividend yield of 0.21% indicates limited returns for dividend-seeking investors. If you invested $1000 you would be paid $2.10 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Diagnostics and Imaging
Imaging equipment drives sales and higher‑margin service revenue; technological upgrades and AI could support demand, though hospital budgets and reimbursement affect timing.
Life Sciences Growth
Bioprocessing and tools for biologics offer expansion opportunities as biologics production rises, but competition and capital intensity can affect margins.
Global Service Network
Recurring revenue from service contracts and consumables provides stability and customer ties, yet geographic exposure and supply chains can influence performance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
